On April 16, 2019, the FDA ordered all manufacturers of surgical mesh intended for transvaginal repair of anterior compartment prolapse (cystocele) to stop.
The meshes are also sometimes offered as a treatment for women suffering from pelvic organ prolapse. Pelvic organ prolapse affects up to half of women who have had children, and occurs when a pelvic organ – such as the bladder, rectum or uterus – “sags” and moves out of place.
Vaginal mesh surgery should only be used as a "last resort" to treat pelvic organ prolapse and urinary incontinence, it was widely reported today. Mesh surgery has seen thousands of women complain of devastating side effects, including pain, bleeding, bowel problems and.